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LETTERS
Leptospira Serovar 
as Prognostic 
Factor 
To the Editor: Herrmann-Storck 
et al. (1) investigated prognostic fac-
tors of leptospirosis and concluded 
that infection with Leptospira interro-
gans serovar Icterohemorrhagiae was 
linked to severe outcomes. We have 
concerns about this conclusion.
These researchers were compar-
ing clinical severity of disease among 
patients for whom serovars of infecting 
isolates had been identiﬁ  ed. However, 
in that study, blood culture was per-
formed for only 88 (52%) of 168 case-
patients, and serovars were identiﬁ  ed 
for 40 (73%) of 55 Leptospira strains 
isolated. Expecting these 40 patients 
(24% of total) to represent all case-
patients in the study is unjustiﬁ  ed. 
Also, the authors evaluated poten-
tial risk factors among these patients 
by applying a multivariable logistic re-
gression model. This process is ques-
tionable. First, the sample size of 40 is 
not large enough to warrant multivari-
able analysis with 9 independent vari-
ables. Actually, only 8 case-patients 
had severe disease, although at least 10 
outcomes are required for variables in 
a logistic regression model (2).
Second, the model selected is in-
appropriate. Variables such as throm-
bocytopenia, hyperneutrophilia, hy-
peramylasemia, and elevated asparate 
aminotransferase levels are laboratory 
ﬁ  ndings of severe leptospirosis (and 
not risk factors of disease). These fac-
tors should not be included in a mul-
tiple logistic regression model as con-
founders. We believe it is premature to 
reach a conclusion about the associa-
tion between Leptospira serovars and 
clinical severity from the data present-
ed by Herrmann-Storck et al.
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In response: We thank Suzuki and 
Ariyoshi for their letter (1). Identiﬁ  ca-
tion of serovar and species can only be 
accomplished by isolating Leptospira 
strains, and obtaining isolates and 
identifying the serovar and species are 
especially difﬁ  cult for human cases of 
leptospirosis. The bacteria are present 
in blood for only 1 week after the onset 
of the disease; they also are fastidious 
and difﬁ  cult to grow. Serologic testing 
gives only a possible serogroup, but it 
is the only diagnostic tool for conﬁ  rm-
ing patients’ infection after 1 week of 
disease. A strength of our study (2) is 
that it contains extensive epidemio-
logic, clinical, and biological data and 
provides a broad collection of identi-
ﬁ  ed strains.
Including laboratory ﬁ  ndings 
such as thrombocytopenia, hyperneu-
trophilia, and hyperamylasemia in the 
model was appropriate for the follow-
ing reasons. First, they were not used 
to establish the deﬁ  nition of severity. 
Second, the variables included in the 
model were deﬁ   ned, not according 
to the norms but at a given level far 
above the norms (thrombocytopenia 
<50 g/L, hyperneutrophilia >12 g/L, 
amylase >285 U/L), which have been 
recently suggested as possible predic-
tors of severity in other reports.
We are aware that the statistical 
model has its limits in the context of 
this retrospective study. We must point 
out that the conclusion of the indepen-
dent involvement of Leptospira sero-
var Icterhoaemorragiae in severity is 
made in the context of Guadeloupe 
with its particular ecology and insular 
features, and results were compared 
with those for given cocirculating 
strains that are sometimes different 
in other areas of the world. The real 
implication of our study is the oppor-
tunity it presents to explore some viru-
lence factors in this particular serovar, 
to compare the results with those of 
other studies conducted in other areas 
with the same tools of identiﬁ  cation, 
and to pave the way for a much larger 
prospective study in the region. 
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